Daily Insider Ratings Round-Up 4/15/20

InsiderInsights’ Daily Round-Up articles rate the “Significance” of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the “Significance” of an insider transaction, however, and often not even the most important one.

When a new insider transaction occurs, our programs mathematically score the significance of the company’s 3-month insider profile based on numerous criteria programmed into our expert system.

Stocks that achieve an InsiderInsights Company Rating of “Significant” and “Leaning” Bullish or Bearish have been independently validated to generate alpha as a group and should be considered by investors looking for new long and short investments.

Seasonal Note: Insider filing volumes are in a seasonally slow period for the remainder of April, as companies close trading windows to insiders until after March-quarter financials are released. Insider trades pick up again in May, but there are still plenty of profitable signals to follow from insiders during slow months like April.

———————-

On Today’s Tables:

Insider trades were rated Significant at:

• Simply Good Foods (SMPL),
• National CineMedia (NCMI), and
• Myovant Sciences (MYOV).

Insider trades were rated Nearly Significant at:

• Liquidity Services (LQDT).

Insider trades were considered Insignificant at:

• Silvercrest Asset Mgt (SAMG),
• Rubius Therapeutics (RUBY),
• Yunhong CTI (CTIB),
• Apogee Enterprises (APOG),
• Take-Two Interactive (TTWO),
• Okta (OKTA),
• Copart (CPRT),
• Cadence Design (CDNS),
• Alteryx (AYX), and
• Aprea Therapeutics (APRE).

There is a Conflicted Insider Signal (both purchases & sales) at:

• Huntington Ingalls (HII), and
• Cloudera (CLDR).

---

Insider Purchases

#:	Filer Name	Insider Titles	Company Name	Ticker	TransType	Dollar Value
1	Sumitomo Chemical	BO	Myovant Sciences	MYOV	AB	$1,456,651
2	Kilts James M	DIR	Simply Good Foods	SMPL	B	$783,122
3	Standard General	BO	National CineMedia	NCMI	B	$770,220
4	Bilden Philip M	DIR	Huntington Ingalls	HII	AB	$600,864
5	Johnson Lloyd Emerson	DIR	Apogee Enterprises	APOG	B	$471,306
6	Angrick William P	CB,CEO,BO	Liquidity Services	LQDT	AB	$418,435
7	Li Yubao	DIR,BO	Yunhong CTI	CTIB	JB*	$260,000
8	Goolsby Michelle P	DIR	Simply Good Foods	SMPL	B	$167,350
9	Gray John Allen	MD	Silvercrest Asset Mgt	SAMG	AB	$99,987
10	Cagnoni Pablo J	CEO,PR,DIR	Rubius Therapeutics	RUBY	B	$98,694

Insider Sales

#:	Filer Name	Insider Titles	Company Name	Ticker	TransType	Dollar Value
1	Johnson Willis J	CB,DIR	Copart	CPRT	S	$71,319,280
2	Zelnick Strauss	CB,CEO	Take-Two Interactive	TTWO	AS	$26,173,026
3	Slatoff Karl	PR	Take-Two Interactive	TTWO	AS	$26,173,026
4	Icahn Carl C	BO	Cloudera	CLDR	S	$11,655,120
5	Grady Patrick W	DIR	Okta	OKTA	AS	$6,654,502
6	Race Charles	O	Okta	OKTA	AS	$6,622,525
7	Kdev Inv Ab	BO	Aprea Therapeutics	APRE	JS*	$6,579,625
8	Losch William E	CFO	Okta	OKTA	AS	$3,996,150
9	Devgan Anirudh	PR	Cadence Design	CDNS	AS	$3,766,917
10	Stoecker Dean	CB,CEO,BO	Alteryx	AYX	AS	$3,247,411

Source: InsiderInsights.com. Key to Insider Title and Trans Type Codes: B = Open-market Buy; AB = 10b5-1 (automatic) Buy; JB* = Buy indicated as being open-market but not confirmed by trading price range and volume for the session. S = Open-market Sale; AS = 10b5-1 (automatic) Sale; JS* = Sale indicated as being open-market but not confirmed by trading price range and volume for the session.

Did you miss our Previous Daily Round-Up?

If you’re serious about using insider data in your investment process, you can’t find a better source of investment ideas (or a better value!) than our Daily Ratings Reports!

Trials have been turned off to our MarketPlace after we uploaded 2 Historically HUGE Bonus Reports containing all the active, “Significant” insider signals generated during the March Market Madness. They are just too valuable to simply give away to trial users with no intention of subscribing. So Subscribe Now, and be prepared when the market next opens!

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.